| Authors | Ouidad Zehou, Salah Ferkal, Pierre Brugieres, Sébastien Barbarot, Sylvie Bastuji-Garin, Patrick Combemale, Laurence Valeyrie-Allanore, Emilie Sbidian, Pierre Wolkenstein |
| Journal | The Journal of investigative dermatology
(J Invest Dermatol)
Vol. 139
Issue 3
Pg. 718-720
(03 2019)
ISSN: 1523-1747 [Electronic] United States |
| PMID | 30339775
(Publication Type: Clinical Trial, Clinical Trial, Phase II, Letter, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Immunosuppressive Agents
- Everolimus
|
| Topics |
- Adult
- Everolimus
(therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Magnetic Resonance Imaging
- Male
- Neurofibroma, Plexiform
(epidemiology, therapy)
- Neurofibromatosis 1
(epidemiology)
- Young Adult
|
